2023 - Research.com Biology and Biochemistry in Netherlands Leader Award
His scientific interests lie mostly in Cancer research, Cell biology, Gene, Molecular biology and Cancer. His Cancer research research incorporates elements of Cisplatin, Mutation, Immunology, Poly Polymerase Inhibitor and Breast cancer. Jos Jonkers has included themes like Replication fork protection, Regulation of gene expression, Receptor and Histone in his Cell biology study.
Gene is the subject of his research, which falls under Genetics. His studies in Molecular biology integrate themes in fields like Transgene, Cre recombinase and DNA, DNA damage. His biological study spans a wide range of topics, including Precision medicine, Pathology and Drug discovery.
Jos Jonkers spends much of his time researching Cancer research, Breast cancer, Cancer, Carcinogenesis and Internal medicine. The concepts of his Cancer research study are interwoven with issues in Olaparib, PARP inhibitor, Cisplatin, Immunology and DNA repair. His work carried out in the field of PARP inhibitor brings together such families of science as Homologous recombination and Poly Polymerase Inhibitor.
His Breast cancer research includes themes of Metastasis and Pathology. His Cancer study combines topics in areas such as Germline mutation, Gene and In vivo. His study looks at the relationship between DNA damage and fields such as Molecular biology, as well as how they intersect with chemical problems.
The scientist’s investigation covers issues in Cancer research, Breast cancer, Cancer, Homologous recombination and PARP inhibitor. The Cancer research study combines topics in areas such as DNA damage, Cancer cell, Poly ADP ribose polymerase, Gene and Genetic screen. His Breast cancer study incorporates themes from Cadherin, PTEN, Cisplatin and In vivo.
His study in Cancer is interdisciplinary in nature, drawing from both Biobank and CRISPR. His Homologous recombination study also includes
Jos Jonkers spends much of his time researching Cancer research, PARP inhibitor, Breast cancer, Homologous recombination and Cell biology. The study incorporates disciplines such as Cancer cell, Cancer, Genetically Engineered Mouse, DNA damage and Genetic screen in addition to Cancer research. His PARP inhibitor research incorporates themes from Mutation, T cell, Olaparib and Tumor microenvironment.
His work deals with themes such as CRISPR, Carcinoma and Oncology, which intersect with Breast cancer. His Homologous recombination research is multidisciplinary, incorporating elements of Polymerase, Poly ADP ribose polymerase and Mutant. His studies deal with areas such as Immunity, DNA and Genome instability as well as Cell biology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Landscape of somatic mutations in 560 breast cancer whole-genome sequences
Serena Nik-Zainal;Serena Nik-Zainal;Helen Davies;Johan Staaf;Manasa Ramakrishna.
Patient-derived xenograft models: an emerging platform for translational cancer research.
Manuel Hidalgo;Frederic Amant;Andrew V. Biankin;Eva Budinská.
Cancer Discovery (2014)
Pan-cancer analysis of whole genomes
Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart.
IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis.
Seth B. Coffelt;Kelly Kersten;Chris W. Doornebal;Jorieke Weiden.
Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer.
Jonkers J;Meuwissen R;van der Gulden H;Peterse H.
Nature Genetics (2001)
High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs
Sven Rottenberg;Janneke E. Jaspers;Ariena Kersbergen;Eline van der Burg.
Proceedings of the National Academy of Sciences of the United States of America (2008)
53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers
Peter Bouwman;Amal Mahmoud Aly;Jose M. Escandell;Mark Pieterse.
Nature Structural & Molecular Biology (2010)
Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum
Silvia Marino;Marc Vooijs;Hanneke van der Gulden;Jos Jonkers.
Genes & Development (2000)
Exosome Transfer from Stromal to Breast Cancer Cells Regulates Therapy Resistance Pathways
Mirjam C. Boelens;Tony J. Wu;Barzin Y. Nabet;Bihui Xu.
Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells
Ate Loonstra;Marc Vooijs;H. Berna Beverloo;Bushra Al Allak.
Proceedings of the National Academy of Sciences of the United States of America (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: